As of May 26
| -0.13 / -2.02%|
The 9 analysts offering 12-month price forecasts for MorphoSys AG have a median target of 3.63, with a high estimate of 15.00 and a low estimate of 2.75. The median estimate represents a -42.94% decrease from the last price of 6.37.
The current consensus among 9 polled investment analysts is to Sell stock in MorphoSys AG. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.